|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash and due from banks | ||||||||||||||||
| Interest bearing deposits | ||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||
| Securities available for sale | ||||||||||||||||
| Securities held to maturity (fair value 12/31/13: $22,471) | ||||||||||||||||
| Restricted equity securities | ||||||||||||||||
| Loans, net of allowance for loan losses, 3/31/15 and 12/31/14: $6,500 | ||||||||||||||||
| Foreclosed assets | ||||||||||||||||
| Premises and equipment, net | ||||||||||||||||
| Bank owned life insurance | ||||||||||||||||
| Accrued interest receivable | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities: | ||||||||||||||||
| Non-interest bearing deposits | ||||||||||||||||
| Interest bearing deposits | ||||||||||||||||
| Total deposits | ||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||
| Short-term borrowings | ||||||||||||||||
| Long-term borrowings | ||||||||||||||||
| FHLB borrowings | ||||||||||||||||
| Junior subordinated notes | ||||||||||||||||
| Accrued interest payable | ||||||||||||||||
| Other liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Shareholders' equity: | ||||||||||||||||
| Preferred stock, no par value; 10,000,000 shares authorized; no shares issued and outstanding at March 31, 2015 and December 31, 2014 | ||||||||||||||||
| Common stock, no par value; 10,000,000 shares authorized; 4,951,653 shares issued and outstanding at March 31, 2015 and 4,932,035 shares issued and outstanding at December 31, 2014 | ||||||||||||||||
| Retained earnings | ||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||
| Total shareholders' equity | ||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||
Loading...
